Finepoint Capital LP Q2 2024 Filing

Filed August 13, 2024

Portfolio Value

$352.3B

Holdings

25

Report Date

Q2 2024

Filing Type

13F-HR

All Holdings (25 positions)

#StockSharesValue% PortfolioType
1
LBRDKLIBERTY BROADBAND CORP
1,994,510$109K0.00%
2
RVMDREVOLUTION MEDICINES INC
729,464$28K0.00%
3
ASNDASCENDIS PHARMA A/S
189,272$25K0.00%
4
SWTXSPRINGWORKS THERAPEUTICS INC
638,352$24K0.00%
5
ARGXARGENX SE
54,028$23K0.00%
6
SRPTSAREPTA THERAPEUTICS INC
132,835$20K0.00%
7
MLTXMOONLAKE IMMUNOTHERAPEUTICS
388,835$17K0.00%
8
ARVNARVINAS INC
574,378$15K0.00%
9
TVTXTRAVERE THERAPEUTICS INC
1,776,728$14K0.00%
10
ACADACADIA PHARMACEUTICALS INC
905,384$14K0.00%
11
CYTKCYTOKINETICS INC
256,449$13K0.00%
12
GLPGGALAPAGOS NV
542,762$13K0.00%
13
RLAYRELAY THERAPEUTICS INC
1,605,346$10K0.00%
14
PRTAPROTHENA CORP PLC
433,471$8K0.00%
15
EYPTEYEPOINT PHARMACEUTICALS INC
707,404$6K0.00%
16
SLDBSOLID BIOSCIENCES INC
961,251$5K0.00%
17
MONEYHERO LIMITED
895,000$00.00%
18
CLDWWCALIDI BIOTHERAPEUTICS INC
655,200$00.00%
19
LAKESHORE BIOPHARMA CO LTD
489,999$00.00%
20
CCIXCHURCHILL CAPITAL CORP VII
548,000$00.00%
21
SWIFTMERGE ACQUISITION CORP
490,000$00.00%
22
CDAQFCOMPASS DIGITAL ACQUISITION CORP
459,906$00.00%
23
MARBLEGATE ACQUISITION CORP
735,000$00.00%
24
CALIDI BIOTHERAPEUTICS INC
125,000$00.00%
25
CNDAWCONCORD ACQUISITION CORP II
408,333$00.00%